Health
Study: Hydroxychloroquine plus azithromycin linked to significant cardiovascular risks – News-Medical.Net
The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM.
Reviewed by Emily Henderson, B.Sc.Aug 25 2020
The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM. This network study, led by the Observational Health Data Sciences and Informatics community, was recently published in Lancet Rheumatology.
OHDSI has established an international network of researchers and observational health databases with a…
Continue Reading
